HEXIM1 and melanoma: Reduced HEXIM1 protein levels have been observed in metastatic breast cancer (Ketchart et al., 2013), melanoma (Tan et al., 2016), and acute leukemia (Devaraj et al., 2016, Huang et al., 2016).